Related Experiment Videos
Trigeminal neuralgia: current concepts and management.
Journal of the Indian Medical Association
|May 23, 2002
Summary
Trigeminal neuralgia, a common cranial nerve pain, is diagnosed via history. Carbamazepine is the primary treatment, with alternative options like Gasserian rhizolysis or microvascular decompression available.
Area of Science:
- Neurology
- Pain Management
- Neurosurgery
Background:
- Trigeminal neuralgia is the most common cranial neuralgia, characterized by stabbing facial pain.
- Accurate patient history is crucial for diagnosis, often negating the need for tests in the absence of neurological abnormalities.
Purpose of the Study:
- To outline the diagnostic considerations and available management options for trigeminal neuralgia.
- To highlight the first-line pharmacotherapy and alternative treatment modalities.
Main Methods:
- Review of diagnostic criteria emphasizing clinical history.
- Categorization of management strategies into pharmacotherapy, destructive procedures (surgical and non-surgical), and non-destructive procedures.
Main Results:
- Pharmacotherapy options include mono- and combination therapies with anticonvulsants, add-on drugs, and antidepressants/anxiolytics.
- Destructive procedures encompass injections, radiofrequency thermocoagulation, surgical methods like neurectomy, tractotomy, and radiosurgery.
- Carbamazepine remains the first-line pharmacotherapy, with percutaneous Gasserian rhizolysis and microvascular decompression as common alternative approaches.
Conclusions:
- Accurate history is key for diagnosing trigeminal neuralgia.
- Carbamazepine is the established first-line treatment.
- Percutaneous Gasserian rhizolysis and microvascular decompression are significant alternative treatments.